- Home
- MCRB vs HQI Comparison
MCRB vs HQI Comparison
Compare MCRB & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- HQI
- Stock Information
- Founded
- MCRB 2010
- HQI 2002
- Country
- MCRB United States
- HQI United States
- Employees
- MCRB N/A
- HQI N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- HQI Professional Services
- Sector
- MCRB Health Care
- HQI Consumer Discretionary
- Exchange
- MCRB Nasdaq
- HQI Nasdaq
- Market Cap
- MCRB 165.3M
- HQI 140.2M
- IPO Year
- MCRB 2015
- HQI N/A
- Fundamental
- Price
- MCRB $15.91
- HQI $10.00
- Analyst Decision
- MCRB Hold
- HQI Buy
- Analyst Count
- MCRB 4
- HQI 1
- Target Price
- MCRB $73.67
- HQI $13.00
- AVG Volume (30 Days)
- MCRB 245.4K
- HQI 6.8K
- Earning Date
- MCRB 11-12-2025
- HQI 11-06-2025
- Dividend Yield
- MCRB N/A
- HQI 2.40%
- EPS Growth
- MCRB N/A
- HQI N/A
- EPS
- MCRB 10.22
- HQI 0.17
- Revenue
- MCRB N/A
- HQI $32,610,000.00
- Revenue This Year
- MCRB N/A
- HQI N/A
- Revenue Next Year
- MCRB N/A
- HQI $1.38
- P/E Ratio
- MCRB $1.62
- HQI $52.39
- Revenue Growth
- MCRB N/A
- HQI N/A
- 52 Week Low
- MCRB $6.53
- HQI $8.94
- 52 Week High
- MCRB $24.67
- HQI $15.75
- Technical
- Relative Strength Index (RSI)
- MCRB 44.26
- HQI 53.24
- Support Level
- MCRB $17.00
- HQI $9.30
- Resistance Level
- MCRB $24.67
- HQI $10.30
- Average True Range (ATR)
- MCRB 2.01
- HQI 0.35
- MACD
- MCRB -0.50
- HQI 0.06
- Stochastic Oscillator
- MCRB 15.94
- HQI 70.00
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.